AAAAAA

   
Results: 1-9 |
Results: 9
MEDICAL THERAPY OF ACTIVE CROHNS-DISEASE
Authors: JARNEROT G SANDBERGGERTZEN H TYSK C
Citation: G. Jarnerot et al., MEDICAL THERAPY OF ACTIVE CROHNS-DISEASE, Bailliere's clinical gastroenterology, 12(1), 1998, pp. 73-92
A POPULATION-BASED STUDY OF HLA CLASS-II POLYMORPHISM IN SWEDISH PATIENTS WITH PRIMARY BILIARY-CIRRHOSIS
Authors: LINDGREN S WASSMUTH R DEPPNER F DANIELSSON A HULTCRANTZ R LOOF L OLSON R PRYTZ H SANDBERGGERTZEN H WALLERSTEDT S
Citation: S. Lindgren et al., A POPULATION-BASED STUDY OF HLA CLASS-II POLYMORPHISM IN SWEDISH PATIENTS WITH PRIMARY BILIARY-CIRRHOSIS, Hepatology, 28(4), 1998, pp. 1509-1509
PRIMARY AMYLOIDOSIS WITH SPONTANEOUS SPLENIC RUPTURE, CHOLESTASIS, AND LIVER-FAILURE TREATED WITH EMERGENCY LIVER-TRANSPLANTATION
Authors: SANDBERGGERTZEN H ERICZON BG BLOMBERG B
Citation: H. Sandberggertzen et al., PRIMARY AMYLOIDOSIS WITH SPONTANEOUS SPLENIC RUPTURE, CHOLESTASIS, AND LIVER-FAILURE TREATED WITH EMERGENCY LIVER-TRANSPLANTATION, The American journal of gastroenterology, 93(11), 1998, pp. 2254-2256
CLINICAL-SIGNIFICANCE OF PLATELET SIZE IN INFLAMMATORY BOWEL-DISEASE - REBUTTAL
Authors: JAREMO P SANDBERGGERTZEN H
Citation: P. Jaremo et H. Sandberggertzen, CLINICAL-SIGNIFICANCE OF PLATELET SIZE IN INFLAMMATORY BOWEL-DISEASE - REBUTTAL, Thrombosis and haemostasis, 77(1), 1997, pp. 219-219
PLATELET DENSITY AND SIZE IN INFLAMMATORY BOWEL-DISEASE
Authors: JAREMO P SANDBERGGERTZEN H
Citation: P. Jaremo et H. Sandberggertzen, PLATELET DENSITY AND SIZE IN INFLAMMATORY BOWEL-DISEASE, Thrombosis and haemostasis, 75(4), 1996, pp. 560-561
NATURAL-HISTORY AND PROGNOSTIC FACTORS IN 305 SWEDISH PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS
Authors: BROOME U OLSSON R LOOF L BODEMAR G HULTCRANTZ R DANIELSSON A PRYTZ H SANDBERGGERTZEN H WALLERSTEDT S LINDBERG G
Citation: U. Broome et al., NATURAL-HISTORY AND PROGNOSTIC FACTORS IN 305 SWEDISH PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS, Gut, 38(4), 1996, pp. 610-615
CANCER RISK IN PRIMARY BILIARY-CIRRHOSIS - A POPULATION-BASED STUDY FROM SWEDEN
Authors: LOOF L ADAMI HO SPAREN P DANIELSSON A ERIKSSON LS HULTCRANTZ R LINDGREN S OLSSON R PRYTZ H RYDEN BO SANDBERGGERTZEN H WALLERSTEDT S
Citation: L. Loof et al., CANCER RISK IN PRIMARY BILIARY-CIRRHOSIS - A POPULATION-BASED STUDY FROM SWEDEN, Hepatology, 20(1), 1994, pp. 101-104
OPTIMUM DOSE OF OLSALAZINE FOR MAINTAINING REMISSION IN ULCERATIVE-COLITIS
Authors: TRAVIS SPL TYSK C DESILVA HJ SANDBERGGERTZEN H JEWELL DP JARNEROT G
Citation: Spl. Travis et al., OPTIMUM DOSE OF OLSALAZINE FOR MAINTAINING REMISSION IN ULCERATIVE-COLITIS, Gut, 35(9), 1994, pp. 1282-1286
PLATELET DENSITY, SIZE AND RELEASE REACTION IN PATIENTS WITH INFLAMMATORY BOWEL-DISEASE
Authors: SANDBERGGERTZEN H JAREMO P JARNEROT G
Citation: H. Sandberggertzen et al., PLATELET DENSITY, SIZE AND RELEASE REACTION IN PATIENTS WITH INFLAMMATORY BOWEL-DISEASE, Gastroenterology, 106(4), 1994, pp. 10000766-10000766
Risultati: 1-9 |